|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/675 | |
| A61K 45/06 | |||
| A61K 31/517 | |||
| A61K 31/522 | |||
| A61K 31/662 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2552452 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11709746.9 |
| Europos patento paraiškos padavimo data | 2011-03-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/054548 |
| Data | 2011-03-24 |
| (87) | Numeris | WO 2011/120870 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 10290177 | 2010-04-01 | EP |
| (72) |
DEUTSCH, Eric, FR
VOZENIN, Marie Catherine, FR
BOURHIS, Jean, FR
|
| (73) |
Université Paris-Sud 11,
15, rue Georges Clémenceau, 91405 Orsay Cedex,
FR
Institut Gustave Roussy (IGR), 39, rue Camille Desmoulins, 94800 Villejuif, FR |
| (54) | EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer |
| EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer |